Stochastic modeling of b lymphocyte terminal differentiation and its suppression by dioxin

BMC Systems Biology

Volumn 4, Issue , 2010, Pages

  Zhang, Qiang ^a   Bhattacharya, Sudin ^a   Kline, Douglas E ^b   Crawford, Robert B ^b   Conolly, Rory B ^c   Thomas, Russell S ^a   Kaminski, Norbert E ^b   Andersen, Melvin E ^a  

^a HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; DIOXIN; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDE;

ANIMAL; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; METABOLISM; METHODOLOGY; MOUSE; STATISTICS; SYSTEMS BIOLOGY;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; DIOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDES; MICE; RECEPTORS, ARYL HYDROCARBON; STOCHASTIC PROCESSES; SYSTEMS BIOLOGY; TETRACHLORODIBENZODIOXIN;

EID: 77950525353     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-4-40     Document Type: Article

References (104)

1. Shapiro-Shelef M, Calame K. Regulation of plasma-cell development. Nat Rev Immunol 2005, 5:230-242. 10.1038/nri1572, 15738953.
2. Calame KL. Plasma cells: finding new light at the end of B cell development. Nat Immunol 2001, 2:1103-1108. 10.1038/ni1201-1103, 11725300.
3. Peden-Adams MM, Keller JM, Eudaly JG, Berger J, Gilkeson GS, Keil DE. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol Sci 2008, 104:144-154. 10.1093/toxsci/kfn059, 18359764.
4. Salazar KD, de la Rosa P, Barnett JB, Schafer R. The polysaccharide antibody response after Streptococcus pneumoniae vaccination is differentially enhanced or suppressed by 3,4-dichloropropionanilide and 2,4-dichlorophenoxyacetic acid. Toxicol Sci 2005, 87:123-133. 10.1093/toxsci/kfi244, 15976183.
5. Dooley RK, Holsapple MP. Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: I. The role of the B lymphocyte. Immunopharmacology 1988, 16:167-180. 10.1016/0162-3109(88)90005-7, 3267010.
6. Tucker AN, Vore SJ, Luster MI. Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmacol 1986, 29:372-377.
7. Sulentic CE, Holsapple MP, Kaminski NE. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells. Mol Pharmacol 1998, 53:623-629.
8. Kerkvliet NI. Recent advances in understanding the mechanisms of TCDD immunotoxicity. Int Immunopharmacol 2002, 2:277-291. 10.1016/S1567-5769(01)00179-5, 11811931.
9. Poland A, Knutson JC. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 1982, 22:517-554. 10.1146/annurev.pa.22.040182.002505, 6282188.
10. Huang S, Guo YP, May G, Enver T. Bifurcation dynamics in lineage-commitment in bipotent progenitor cells. Dev Biol 2007, 305:695-713. 10.1016/j.ydbio.2007.02.036, 17412320.
11. Chickarmane V, Troein C, Nuber UA, Sauro HM, Peterson C. Transcriptional dynamics of the embryonic stem cell switch. PLoS Comput Biol 2006, 2:e123. 10.1371/journal.pcbi.0020123, 1570179,1570179, 16978048.
12. Maamar H, Raj A, Dubnau D. Noise in gene expression determines cell fate in Bacillus subtilis. Science 2007, 317:526-529. 10.1126/science.1140818, 17569828.
13. Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006, 7:885-896. 10.1038/nrm2066, 17139329.
14. Calame K. Activation-dependent induction of Blimp-1. Curr Opin Immunol 2008, 20:259-264. 10.1016/j.coi.2008.04.010, 18554885.
15. Lin KI, Angelin-Duclos C, Kuo TC, Calame K. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol Cell Biol 2002, 22:4771-4780. 10.1128/MCB.22.13.4771-4780.2002, 133916, 12052884.
16. Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A, Giltnane JM, Yang L, Zhao H, Calame K, Staudt LM. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 2002, 17:51-62. 10.1016/S1074-7613(02)00335-7, 12150891.
17. Sciammas R, Davis MM. Modular nature of Blimp-1 in the regulation of gene expression during B cell maturation. J Immunol 2004, 172:5427-5440.
18. Vasanwala FH, Kusam S, Toney LM, Dent AL. Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene. J Immunol 2002, 169:1922-1929.
19. Tunyaplin C, Shaffer AL, Angelin-Duclos CD, Yu X, Staudt LM, Calame KL. Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J Immunol 2004, 173:1158-1165.
20. Mora-Lopez F, Reales E, Brieva JA, Campos-Caro A. Human BSAP and BLIMP1 conform an autoregulatory feedback loop. Blood 2007, 110:3150-3157. 10.1182/blood-2007-05-092262, 17682124.
21. Bhattacharya S, Conolly RB, Kaminski NE, Thomas RS, Andersen ME, Zhang Q. A Bistable Switch Underlying B Cell Differentiation and Its Disruption by the Environmental Contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Sci 2010, doi: 10.1093/toxsci/kfq1035.
22. Soro PG, Morales AP, Martinez MJ, Morales AS, Copin SG, Marcos MA, Gaspar ML. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells. J Immunol 1999, 163:611-617.
23. Kallies A, Hasbold J, Tarlinton DM, Dietrich W, Corcoran LM, Hodgkin PD, Nutt SL. Plasma cell ontogeny defined by quantitative changes in blimp-1 expression. J Exp Med 2004, 200:967-977. 10.1084/jem.20040973, 2211847, 15492122.
24. Fairfax KA, Corcoran LM, Pridans C, Huntington ND, Kallies A, Nutt SL, Tarlinton DM. Different kinetics of blimp-1 induction in B cell subsets revealed by reporter gene. J Immunol 2007, 178:4104-4111.
25. Kallies A, Hasbold J, Fairfax K, Pridans C, Emslie D, McKenzie BS, Lew AM, Corcoran LM, Hodgkin PD, Tarlinton DM, Nutt SL. Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1. Immunity 2007, 26:555-566. 10.1016/j.immuni.2007.04.007, 17509907.
26. Klein U, Casola S, Cattoretti G, Shen Q, Lia M, Mo T, Ludwig T, Rajewsky K, Dalla-Favera R. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol 2006, 7:773-782. 10.1038/ni1357, 16767092.
27. Johnson K, Shapiro-Shelef M, Tunyaplin C, Calame K. Regulatory events in early and late B-cell differentiation. Mol Immunol 2005, 42:749-761. 10.1016/j.molimm.2004.06.039, 15829263.
28. Cobaleda C, Schebesta A, Delogu A, Busslinger M. Pax5: the guardian of B cell identity and function. Nat Immunol 2007, 8:463-470. 10.1038/ni1454, 17440452.
29. Delogu A, Schebesta A, Sun Q, Aschenbrenner K, Perlot T, Busslinger M. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity 2006, 24:269-281. 10.1016/j.immuni.2006.01.012, 16546096.
30. Diehl SA, Schmidlin H, Nagasawa M, van Haren SD, Kwakkenbos MJ, Yasuda E, Beaumont T, Scheeren FA, Spits H. STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J Immunol 2008, 180:4805-4815. 2396731, 18354204.
31. Niu H, Ye BH, Dalla-Favera R. Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev 1998, 12:1953-1961. 10.1101/gad.12.13.1953, 316953, 9649500.
32. Rui L, Healy JI, Blasioli J, Goodnow CC. ERK signaling is a molecular switch integrating opposing inputs from B cell receptor and T cell cytokines to control TLR4-driven plasma cell differentiation. J Immunol 2006, 177:5337-5346.
33. Walker SR, Nelson EA, Frank DA. STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas. Oncogene 2007, 26:224-233. 10.1038/sj.onc.1209775, 16819511.
34. Ohkubo Y, Arima M, Arguni E, Okada S, Yamashita K, Asari S, Obata S, Sakamoto A, Hatano M, J OW, et al. A role for c-fos/activator protein 1 in B lymphocyte terminal differentiation. J Immunol 2005, 174:7703-7710.
35. Suh J, Jeon YJ, Kim HM, Kang JS, Kaminski NE, Yang KH. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells. Toxicol Appl Pharmacol 2002, 181:116-123. 10.1006/taap.2002.9403, 12051995.
36. Schneider D, Manzan MA, Yoo BS, Crawford RB, Kaminski N. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells. Toxicol Sci 2009, 108:377-388. 10.1093/toxsci/kfp028, 2664693, 19237549.
37. Sulentic CE, Zhang W, Na YJ, Kaminski NE. 2,3,7,8-tetrachlorodibenzo-p-dioxin, an exogenous modulator of the 3'alpha immunoglobulin heavy chain enhancer in the CH12.LX mouse cell line. J Pharmacol Exp Ther 2004, 309:71-78. 10.1124/jpet.103.059493, 14718603.
38. Kaern M, Elston TC, Blake WJ, Collins JJ. Stochasticity in gene expression: from theories to phenotypes. Nat Rev Genet 2005, 6:451-464. 10.1038/nrg1615, 15883588.
39. Thattai M, van Oudenaarden A. Intrinsic noise in gene regulatory networks. Proc Natl Acad Sci USA 2001, 98:8614-8619. 10.1073/pnas.151588598, 37484, 11438714.
40. Elowitz MB, Levine AJ, Siggia ED, Swain PS. Stochastic gene expression in a single cell. Science 2002, 297:1183-1186. 10.1126/science.1070919, 12183631.
41. Ozbudak EM, Thattai M, Kurtser I, Grossman AD, van Oudenaarden A. Regulation of noise in the expression of a single gene. Nat Genet 2002, 31:69-73. 10.1038/ng869, 11967532.
42. Swain PS, Elowitz MB, Siggia ED. Intrinsic and extrinsic contributions to stochasticity in gene expression. Proc Natl Acad Sci USA 2002, 99:12795-12800. 10.1073/pnas.162041399, 130539, 12237400.
43. Blake WJ, M KA, Cantor CR, Collins JJ. Noise in eukaryotic gene expression. Nature 2003, 422:633-637. 10.1038/nature01546, 12687005.
44. Raser JM, O'Shea EK. Control of stochasticity in eukaryotic gene expression. Science 2004, 304:1811-1814. 10.1126/science.1098641, 1410811, 15166317.
45. Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 2009, 459:428-432. 10.1038/nature08012, 19363473.
46. Kar S, Baumann WT, Paul MR, Tyson JJ. Exploring the roles of noise in the eukaryotic cell cycle. Proc Natl Acad Sci USA 2009, 106:6471-6476. 10.1073/pnas.0810034106, 2672517, 19246388.
47. Wernet MF, Mazzoni EO, Celik A, Duncan DM, Duncan I, Desplan C. Stochastic spineless expression creates the retinal mosaic for colour vision. Nature 2006, 440:174-180. 10.1038/nature04615, 16525464.
48. Lu H, Kaplan BL, Ngaotepprutaram T, Kaminski NE. Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol. J Leukoc Biol 2009, 85:322-329. 10.1189/jlb.0608390, 2631366, 18988696.
49. Springs AE, Karmaus PW, Crawford RB, Kaplan BL, Kaminski NE. Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol. J Leukoc Biol 2008, 84:1574-1584. 10.1189/jlb.0508282, 2614598, 18791168.
50. Fiering S, Whitelaw E, Martin DI. To be or not to be active: the stochastic nature of enhancer action. Bioessays 2000, 22:381-387. 10.1002/(SICI)1521-1878(200004)22:4<381::AID-BIES8>3.0.CO;2-E, 10723035.
51. Zhang Q, Andersen ME, Conolly RB. Binary Gene Induction and Protein Expression in Individual Cells. Theor Biol Med Model 2006, 3:18. 10.1186/1742-4682-3-18, 1488830, 16597340.
52. Yu J, Angelin-Duclos C, Greenwood J, Liao J, Calame K. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol Cell Biol 2000, 20:2592-2603. 10.1128/MCB.20.7.2592-2603.2000, 85475, 10713181.
53. Gyory I, Wu J, Fejer G, Seto E, Wright KL. PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nat Immunol 2004, 5:299-308. 10.1038/ni1046, 14985713.
54. Ren B, Chee KJ, Kim TH, Maniatis T. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev 1999, 13:125-137. 10.1101/gad.13.1.125, 316372, 9887105.
55. Milili M, Gauthier L, Veran J, Mattei MG, Schiff C. A new Groucho TLE4 protein may regulate the repressive activity of Pax5 in human B lymphocytes. Immunology 2002, 106:447-455. 10.1046/j.1365-2567.2002.01456.x, 1782747, 12153506.
56. Eberhard D, Jimenez G, Heavey B, Busslinger M. Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family. Embo J 2000, 19:2292-2303. 10.1093/emboj/19.10.2292, 384353, 10811620.
57. Husebye H, Halaas O, Stenmark H, Tunheim G, Sandanger O, Bogen B, Brech A, Latz E, Espevik T. Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. Embo J 2006, 25:683-692. 10.1038/sj.emboj.7600991, 1383569, 16467847.
58. Kitchens RL, Wang P, Munford RS. Bacterial lipopolysaccharide can enter monocytes via two CD14-dependent pathways. J Immunol 1998, 161:5534-5545.
59. Adalsteinsson D, McMillen D, Elston TC. Biochemical Network Stochastic Simulator (BioNetS): software for stochastic modeling of biochemical networks. BMC Bioinformatics 2004, 5:24. 10.1186/1471-2105-5-24, 408466, 15113411.
60. Gillespie DT. Exact stochastic simulation of coupled chemical reactions. Journal of Physical Chemistry 1977, 81:2340-2361.
61. Ermentrout B. Simulating, Analyzing, and Animating Dynamical Systems: A Guide to XPPAUT for Researchers and Students 2002, Philadelphia, USA: SIAM, 1.
62. Ferrell JE, Xiong W. Bistability in cell signaling: How to make continuous processes discontinuous, and reversible processes irreversible. Chaos 2001, 11:227-236. 10.1063/1.1349894, 12779456.
63. Angeli D, Ferrell JE, Sontag ED. Detection of multistability, bifurcations, and hysteresis in a large class of biological positive-feedback systems. Proc Natl Acad Sci USA 2004, 101:1822-1827. 10.1073/pnas.0308265100, 357011, 14766974.
64. Strogatz SH. Nonliear dynamics and chaos: with applications to physics, biology, chemistry, and engineering 1994, Cambridge: Perseus Books Group, 1.
65. Swain SL, Dutton RW, McKenzie D, Helstrom H, English M. Role of antigen in the B cell response. Specific antigen and the lymphokine IL-5 synergize to drive B cell lymphoma proliferation and differentiation to Ig secretion. J Immunol 1988, 140:4224-4230.
66. Turner CA, Mack DH, Davis MM. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 1994, 77:297-306. 10.1016/0092-8674(94)90321-2, 8168136.
67. North CM, Kim BS, Snyder N, Crawford RB, Holsapple MP, Kaminski NE. TCDD-Mediated Suppression of the in vitro Anti-Sheep Erythrocyte IgM Antibody Forming Cell Response is Reversed by Interferon Gamma. Toxicol Sci 2009, 107:85-92. 10.1093/toxsci/kfn223, 2638643, 18948302.
68. Schneider D, Manzan MA, Crawford RB, Chen W, Kaminski NE. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a. J Pharmacol Exp Ther 2008, 326:463-474. 10.1124/jpet.108.139857, 2562000, 18483191.
69. Crawford RB, Sulentic CE, Yoo BS, Kaminski NE. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation and posttranslational modification of p27kip1 in lipopolysaccharide-activated B cells. Toxicol Sci 2003, 75:333-342. 10.1093/toxsci/kfg199, 12883080.
70. Pomerening JR. Uncovering mechanisms of bistability in biological systems. Curr Opin Biotechnol 2008, 19:381-388. 10.1016/j.copbio.2008.06.009, 18634875.
71. Ferrell JE. Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr Opin Cell Biol 2002, 14:140-148. 10.1016/S0955-0674(02)00314-9, 11891111.
72. Xiong W, Ferrell JE. A positive-feedback-based bistable 'memory module' that governs a cell fate decision. Nature 2003, 426:460-465. 10.1038/nature02089, 14647386.
73. Ferrell JE. Feedback regulation of opposing enzymes generates robust, all-or-none bistable responses. Curr Biol 2008, 18:R244-245. 10.1016/j.cub.2008.02.035, 2832910, 18364225.
74. Palani S, Sarkar CA. Positive receptor feedback during lineage commitment can generate ultrasensitivity to ligand and confer robustness to a bistable switch. Biophys J 2008, 95:1575-1589. 10.1529/biophysj.107.120600, 2483757, 18469073.
75. Sveiczer A, Tyson JJ, Novak B. Modelling the fission yeast cell cycle. Brief Funct Genomic Proteomic 2004, 2:298-307. 10.1093/bfgp/2.4.298, 15163365.
76. Kim JR, Yoon Y, Cho KH. Coupled feedback loops form dynamic motifs of cellular networks. Biophys J 2008, 94:359-365. 10.1529/biophysj.107.105106, 2157222, 17951298.
77. Yu J, Xiao J, Ren X, Lao K, Xie XS. Probing gene expression in live cells, one protein molecule at a time. Science 2006, 311:1600-1603. 10.1126/science.1119623, 16543458.
78. Cai L, Friedman N, Xie XS. Stochastic protein expression in individual cells at the single molecule level. Nature 2006, 440:358-362. 10.1038/nature04599, 16541077.
79. Raj A, Peskin CS, Tranchina D, Vargas DY, Tyagi S. Stochastic mRNA synthesis in mammalian cells. PLoS Biol 2006, 4:e309. 10.1371/journal.pbio.0040309, 1563489,1563489, 17048983.
80. Golding I, Paulsson J, Zawilski SM, Cox EC. Real-time kinetics of gene activity in individual bacteria. Cell 2005, 123:1025-1036. 10.1016/j.cell.2005.09.031, 16360033.
81. Tumang JR, Frances R, Yeo SG, Rothstein TL. Spontaneously Ig-secreting B-1 cells violate the accepted paradigm for expression of differentiation-associated transcription factors. J Immunol 2005, 174:3173-3177.
82. Lai K, Robertson MJ, Schaffer DV. The sonic hedgehog signaling system as a bistable genetic switch. Biophys J 2004, 86:2748-2757. 10.1016/S0006-3495(04)74328-3, 1304145, 15111393.
83. Bhattacharya S, Zhang Q, Andersen ME. The Role of Core Biological Motifs in Dose-Response Modeling: An Example with Switch-Like Circuits. Systems Biology in Drug Discovery and Development 2009, Hoboken, New Jersey: John Wiley & Sons, Young D, Michelson S, .
84. Losick R, Desplan C. Stochasticity and cell fate. Science 2008, 320:65-68. 10.1126/science.1147888, 2605794, 18388284.
85. Chang HH, Hemberg M, Barahona M, Ingber DE, Huang S. Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 2008, 453:544-547. 10.1038/nature06965, 18497826.
86. Weinberger LS, Burnett JC, Toettcher JE, Arkin AP, Schaffer DV. Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell 2005, 122:169-182. 10.1016/j.cell.2005.06.006, 16051143.
87. Suel GM, Kulkarni RP, Dworkin J, Garcia-Ojalvo J, Elowitz MB. Tunability and noise dependence in differentiation dynamics. Science 2007, 315:1716-1719. 10.1126/science.1137455, 17379809.
88. Lutz WK. A true threshold dose in chemical carcinogenesis cannot be defined for a population, irrespective of the mode of action. Hum Exp Toxicol 2000, 19:566-568. discussion 571-562, 10.1191/096032700701546488, 11211995.
89. Manz RA, Thiel A, Radbruch A. Lifetime of plasma cells in the bone marrow. Nature 1997, 388:133-134. 10.1038/40540, 9217150.
90. Ahuja A, Anderson SM, Khalil A, Shlomchik MJ. Maintenance of the plasma cell pool is independent of memory B cells. Proc Natl Acad Sci USA 2008, 105:4802-4807. 10.1073/pnas.0800555105, 2290811, 18339801.
91. Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KG, Dorner T, Hiepe F. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 2006, 6:741-750. 10.1038/nri1886, 16977339.
92. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872. 10.1016/j.cell.2007.11.019, 18035408.
93. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920. 10.1126/science.1151526, 18029452.
94. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146. 10.1038/nature06534, 18157115.
95. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, Sridharan R, Clark AT, Plath K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA 2008, 105:2883-2888. 10.1073/pnas.0711983105, 2268554, 18287077.
96. Nutt SL. B-cell identity--commitment is not forever. N Engl J Med 2008, 358:82-83. 10.1056/NEJMcibr0707112, 18172181.
97. Welner RS, Pelayo R, Kincade PW. Evolving views on the genealogy of B cells. Nat Rev Immunol 2008, 8:95-106. 10.1038/nri2234, 18204470.
98. Xie H, Ye M, Feng R, Graf T. Stepwise reprogramming of B cells into macrophages. Cell 2004, 117:663-676. 10.1016/S0092-8674(04)00419-2, 15163413.
99. Cobaleda C, Jochum W, Busslinger M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 2007, 449:473-477. 10.1038/nature06159, 17851532.
100. Fujita N, Jaye DL, Geigerman C, Akyildiz A, Mooney MR, Boss JM, Wade PA. MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation. Cell 2004, 119:75-86. 10.1016/j.cell.2004.09.014, 15454082.
101. Lee SC, Bottaro A, Chen L, Insel RA. Mad1 is a transcriptional repressor of Bcl-6. Mol Immunol 2006, 43:1965-1971. 10.1016/j.molimm.2005.11.017, 16423395.
102. Ochiai K, Katoh Y, Ikura T, Hoshikawa Y, Noda T, Karasuyama H, Tashiro S, Muto A, Igarashi K. Plasmacytic transcription factor Blimp-1 is repressed by Bach2 in B cells. J Biol Chem 2006, 281:38226-38223. 10.1074/jbc.M607592200, 17046816.
103. Sciammas R, Shaffer AL, Schatz JH, Zhao H, Staudt LM, Singh H. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 2006, 25:225-236. 10.1016/j.immuni.2006.07.009, 16919487.
104. Hahn ME, Allan LL, Sherr DH. Regulation of constitutive and inducible AHR signaling: complex interactions involving the AHR repressor. Biochem Pharmacol 2009, 77:485-497. 10.1016/j.bcp.2008.09.016, 2701375, 18848529.